Objectives: The present study evaluated the relationship between the 2011 American College of Rheumatology fibromyalgia (FM) survey criteria and quantitative sensory testing (QST).
T he construct of "centralized pain" refers to central nervous system mechanisms associated with augmented pain and sensory processing. Clinically, it manifests as widespread chronic pain often independent of nociceptive input, combined with fatigue, sleep, cognitive, and mood problems. 1 Laboratory-based quantitative sensory testing (QST) has shown that individuals with centralized pain exhibit global hypersensitivity to painful and nonpainful sensory stimulation, 2,3 facilitated temporal summation (TS) of pain, 4 and decreased endogenous analgesia 5 compared to pain-free controls. Neuroimaging studies in centralized pain states substantiate these findings showing evidence of augmented sensory-evoked activity, 6, 7 as well as alterations in connectivity, structure, and neurochemistry in pain processing brain regions. 8, 9 Individuals with centralized pain respond preferentially to centrally acting treatments (tricyclics, serotonin-norepinephrine reuptake inhibitors, gabapentinoids, cognitive behavioral therapy) and show poor response to opioids and peripheral interventions such as surgery. [10] [11] [12] [13] Fibromyalgia (FM) is the prototypical centralized pain condition. 1 FM was previously diagnosed on the presence of widespread pain at multiple discrete "tender points." 14 In 2010, the American College of Rheumatology released new diagnostic criteria for FM that eliminated tender point palpation but added assessments of somatic symptoms and pain distribution. 15 A modified version of self-report criteria for research that did not require a physician interview was released in 2011. 16 The 2011 criteria can be used in a dichotomous manner for FM classification or as a continuous "FM score," with higher scores indicating increased symptom severity and more painful body sites.
We previously reported that FM scores predicted perioperative and postsurgical outcomes in patients with pain conditions other than FM. For every 1-point increase in FM score, there was an adjusted 7 to 9 mg oral morphine equivalent increase in opioid requirement during the inpatient postoperative admission, 13 and an adjusted 18% increased risk of failing to meet the threshold for surgical pain improvement. 12 FM scores also predicted postoperative opioid consumption in females with chronic pelvic pain undergoing hysterectomy with a similar effect size. 12 That the FM survey criteria was independently associated with suboptimal analgesic responses to opioids and peripheral inventions suggests that it may represent a marker of centralized pain, with potential utility across various chronic pain conditions. The present study sought to provide convergent validity for this hypothesis by examining the relationship between FM scores and QST. Patients with knee osteoarthritis (OA) scheduled for total knee arthroplasty (TKA) underwent QST before surgery. We hypothesized that QST outcomes would be associated with FM scores, with higher FM scores corresponding to increased pressure pain sensitivity at multiple body sites and dysfunctional pain modulation measured by TS and conditioned pain modulation (CPM). We further hypothesized that pain sensitivity at the surgical knee and at remote body sites would be more strongly associated in OA patients with higher FM scores.
MATERIALS AND METHODS
Approval was attained from the University of Michigan Institutional Review Board. Our reporting conforms to the Strengthening the Reporting of Observational studies in Epidemiology (STROBE) Statement.
Study Participants
Patients 18 years old and above scheduled for TKA at the University of Michigan were recruited from a knee surgery informational workshop between January 17, 2012 and August 25, 2016, as a subset of the parent Analgesic Outcomes Study (AOS). 12,13 AOS light phenotyping consisted of a battery of self-report measures acquired on the day of surgery. Patients in the present study enrolled in an additional deep phenotyping visit of QST completed within 1 month before surgery (ie, these patients completed both light and deep phenotyping protocols).
Exclusion criteria included: severe physical impairment (eg, bilateral amputation, blindness, or deafness); severe psychiatric illnesses (eg, schizophrenia, major depression, suicidality, psychotic features, or substance abuse within 2 y); alcohol consumption exceeding 7 drinks per week for females or 14 drinks per week for males within 6 months of screening; treatment with an investigational drug within 30 days before testing; analgesic consumption within 8 hours of QST; if the principal investigator determined that the patient was unlikely to be able to complete the study; previous TKA; current pregnancy; current incarceration; life expectancy <1 year; and inability to provide written informed consent.
Light Phenotyping

FM Survey Criteria
The 2011 FM survey criteria, 16 is comprised of the Widespread Pain Index (WPI) and the Symptom Severity score (SS score). The WPI (extrapolated from the Michigan Body Map 17 ) assesses 19 body locations to determine the spatial distribution of pain in the past week, with scores ranging 0 to 19. The SS score evaluates the severity of 3 cardinal FM symptoms (fatigue, trouble thinking or remembering, and waking up tired/unrefreshed), as well as the presence of 3 additional somatic symptoms (pain or cramps in lower abdomen, depression, and headache). The SS score ranges 0 to 12. The WPI and SS score are combined to calculate an overall index of FM severity score (referred to here as the "FM score") ranging 0 to 31. A score of ≥ 13 is required for positive FM classification.
Brief Pain Inventory (BPI)
BPI measures clinical pain using a 4-item subscale assessing overall body pain at its "worst," "least," "current," and "average" in the last week, each on scale of 0 to 10. 18 A composite measure of pain severity is computed from the average of the above 4 items. We also administered a modified version that focused on pain at the surgical knee, ignoring the rest of the body.
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
WOMAC is a 24-item survey with pain, stiffness, and function subscales for patients with knee or hip OA. 19 The pain subscale ranges 0 to 20, with higher values indicating greater pain. The stiffness subscale ranges 0 to 8, with higher values indicating greater joint stiffness. The function subscale ranges 0 to 68, with higher values indicating greater functional impairment. The total score is the sum total of the above 3 subscales.
PainDETECT
PainDETECT is used to screen for neuropathic pain. 20 Total score ranges from 0 to 38. Higher scores indicate an increasing likelihood of a neuropathic component, with scores > 18 suggesting a neuropathic component to the patient's pain is likely.
Coping Strategies Questionnaire (CSQ)
CSQ contains a catastrophizing subscale that is used to measure a patient's ability to cope with their pain and the extent to which they view their pain as threatening. 21 It contains 6 items with a total score of 0 to 36. Higher scores indicate greater pain catastrophizing.
Hospital Anxiety and Depression Scale (HADS)
HADS is composed of depression (0 to 21), anxiety (0 to 21), and positive affect (0 to 18) subscales. 22 Lower scores indicate less depression and anxiety and a more positive affect.
QST
Patients completed deep AOS QST phenotyping within 1 month before surgery. Patients were read scripted instructions and completed practice testing before data collection to reduce testing-related anxiety.
Pressure Pain Sensitivity
Pressure pain sensitivity was assessed at the thumbnail following well-described procedures 23, 24 using the Multimodal Automated Sensory Testing (MAST) system (Arbor Medical Innovations, Ann Arbor, MI). 25 The MAST system delivered computer-controlled pressure to the thumbnail with a mechanically driven 1 cm 2 rubber-tipped probe. A series of pressures of 5 seconds duration were delivered in ascending order to the dominant thumbnail at 4 kgf/cm 2 /s, starting at 0.50 kgf/cm 2 and increasing in 0.50 kgf/cm 2 steps (20-s interstimulus interval). Patients rated pain intensity after each stimulus using a digital 0 to 100 numerical rating scale (NRS) displayed on a touchscreen (0 = no pain; 100 = worst pain imaginable). The test was completed when: (1) the patient reached his or her pain tolerance, (2) the patient reported a pain intensity of ≥ 80/100, or (3) a maximum possible pressure of 10 kgf/cm 2 was delivered. Data were fit to a linear model, from which Pain50-defined as the pressure that evoked a moderate amount pain (ie, 50/ 100)-was interpolated. Additional derived variables include: (1) pressure pain threshold (PPT), which is the first pressure in a series of at least 2 consecutive pressures that produced a NRS > 0; and (2) pressure pain tolerance, defined as the last pressure collected.
PPTs were also assessed bilaterally using a hand-held algometer with a 1 cm 2 flat rubber probe (FPX 50; Wagner Instruments, Greenwich, CT) at the knee scheduled for TKA (surgical knee), the contralateral knee (nonsurgical knee), and several sites distant from the knees. Knees were stimulated 2 cm lateral to the midpoint of the lateral edge of the patella, a site previously studied in knee OA patients. 26 A site on the lower leg lateral to the tibial tuberosity and anterior to the tibial crest was used to assess secondary hyperalgesia relative to the knees. The wrist, serving as a secondary joint site, was tested at the first metacarpophalangeal joint. The midpoint of the upper trapezius was tested as a remote muscle site. All patients were tested at all sites in the same order, counter-balanced between the left and right body side. Pressure was applied manually at a rate of 0.5 kgf/cm 2 /s until the patient indicated an initial sensation of pain, with this being recorded as the PPT. Pressures did not exceed 10 kgf/cm 2 . This procedure was repeated 3 times at each location with the mean PPT used for analysis.
CPM
CPM was performed according to validated methods. 24, 27 Pressures were delivered via 2 MAST actuators positioned on the dominant thumb as a test stimulus and the nondominant thumb as a conditioning stimulus. A continuous test pressure was applied for 30 seconds at an intensity individually calibrated for each patient to evoke a moderate level of pain (Pain30-50). Patients rated the pain intensity of the pressure 3 times, 10 seconds apart (ie, at time 10, 20, and 30 s) using a 0 to 100 NRS. CPM was induced 10 to 15 minutes later by applying 60 seconds of continuous Pain30-50 pressure to the nondominant thumbnail. Parallel to the last 30 seconds of conditioning, the test stimulus was reapplied to the dominant thumbnail for 30 seconds and rated 3 times, 10 seconds apart (corresponding to the 40, 50, and 60 s time points of the conditioning stimulus). CPM magnitude was calculated as the difference between the mean of the pain ratings given to the test stimulus before the conditioning stimuli and the mean of the pain ratings of the test stimulus given during the conditioning stimulus. Negative values imply intact inhibitory CPM; positive values reflect deficient CPM.
TS
Twelve pressure stimuli of 1 second duration and equal intensity were delivered in succession to the thumbnail at 1 second intervals using the MAST system. Stimulus intensity was individually calibrated to be 20% above the patient's thumbnail PPT. Patients rated their pain on a 0 to 100 NRS following each stimulus presentation. The pain rating of the first stimulus was subtracted from the 12th and final stimulus to calculate TS scores, where larger numbers indicate increased pain summation.
Statistical Analysis
Patients without complete FM survey criteria were excluded from analysis. Missing item-level data in all other self-report measures were handled according to instructions provided by the author(s) of each instrument. When individual self-report measures were missing in their entirety or could not be scored due to excessive missing items, those measures were not analyzed but all other usable data from that patient remained in the analysis. Technical errors, procedural deviations, and patient refusal to complete portions of the QST battery resulted in missing QST data in some analyses.
Continuous measures are reported as mean ± SD, and categorical variables are reported as frequency (%). Normality was assessed via histograms and q-q plots; nonparametric statistics were used when violations in normality were detected. Bivariate analyses were conducted to determine significant differences between females and males; χ 2 and independent samples t tests were used for categorical and continuous variables, respectively. Associations between FM score and self-report measures were assessed by Pearson correlation. The relationship between FM score and QST was examined using Pearson partial correlations adjusted for age 28 and conducted separately for females and males. The a priori decision to stratify the analysis by sex was based on considerable literature demonstrating significant female-male differences in pain processing and FM, with females generally demonstrating increased clinical and experimental pain, 29, 30 and a higher prevalence of FM. 31, 32 Preliminary visual analysis of the present data also showed increased FM severity in females and a different distribution of FM scores between sexes. Significant correlations were further explored by subgrouping participants into FM score tertiles, consistent with previous assessments of this instrument: females (low = 0 to 4; moderate = 5 to 8; high = 9 to 20) and males (low = 0 to 2; moderate = 3 to 5; high = 6 to 16). [11] [12] [13] These cut-points were calculated from this cohort's distribution of FM scores. Analysis of covariance (ANCOVA) adjusted for age was used to assess for significant differences in QST outcomes between FM score tertiles. Planned comparisons (unadjusted) assessed for differences in estimated marginal means between QST outcomes at each tertile. Spearman ρ was used to examine the relationship between PPT at the surgical knee and PPT at other body sites across FM score tertiles. Statistical analysis was conducted using IBM SPSS version 24 (IBM Corp, Armonk, NY). All analyses were 2-tailed with significance set at P < 0.05.
RESULTS
Participant Demographics
A total of 187 patients were consented for deep phenotyping (Fig. 1) . Cancelled surgeries, patient withdrawals, and missing data resulted in a final data set of 129 (68 female; 61 male) patients (Table 1) . They were primarily Caucasian and older (females, 63.6 ± 8.6 y; males, 64.7 ± 8.7 y). Males were more likely to be Caucasian than females (P = 0.044). There were no significant differences in FM positive classification between sexes.
Sex Differences in Clinical Pain and Symptoms
Females had significantly higher FM scores (P = 0.001), overall body pain (P = 0.020), and pain at their surgical knee (P = 0.042) compared with males as measured by the BPI (Table 1) . Females had significantly higher pain (P = 0.009), stiffness (P = 0.043), and total scores (P = 0.027) on the WOMAC. Females reported greater pain catastrophizing (P = 0.041), anxiety (P = 0.019), and depression (P = 0.046) as measured by HADS.
Sex Differences in QST
Compared with males, females showed significantly greater suprathreshold pressure pain sensitivity at the thumbnail as demonstrated by lower Pain50 (P = 0.017) and tolerance (P = 0.001) values (Table, Supplemental Digital Content 1, http://links.lww.com/CJP/A503). In addition, females were significantly more sensitive at all locations measured by hand-held algometry (all P ≤ 0.013; Table, Supplemental Digital Content 1, http://links.lww.com/CJP/ A503). PPTs at the lower leg and trapezius showed no difference between left and right sides of the body in either sex (paired t tests, all P > 0.05). Laterality in wrist PPT was detected in males (P = 0.022), but not females (P = 0.339). Mean CPM and TS values were positive in males and females, indicating deficient pain inhibition and the presence of pain facilitation at the group level; however, no sex differences were found for either measure: CPM (P = 0.306), TS (P = 0.334).
Correlation Between FM Score and Symptoms
In females, FM scores correlated significantly with all symptom measures (all P ≤ 0.037) except BPI (Supplemental Digital Content 2, http://links.lww.com/CJP/A504). FM scores correlated with all symptom measures in males (all P ≤ 0.043).
Correlation Between FM Score and QST
In females, FM scores correlated with all measures of pressure pain sensitivity (all |r| ≥ 0.27, all P ≤ 0.021) except thumbnail PPT ( Table 2 ), such that higher FM scores were associated with increased pain sensitivity (ie, lower thresholds) throughout the body. These correlations remained significant (all |r| ≥ 0.33, all P ≤ 0.015), with the exception of thumbnail Pain50 (r = −0.243, P = 0.057) and tolerance (r = −0.224, P = 0.08), after excluding patients that satisfied survey criteria for positive FM classification. A series of secondary partial correlations showed that the relationship between FM Score and QST was substantially unchanged when controlling for symptoms that could potentially influence QST responses, including clinical pain severity (BPI, WOMAC), anxiety, and catastrophizing (Supplemental Digital Content 3, http://links.lww.com/CJP/A505).
In addition to static threshold measures of pain sensitivity, females also showed a positive but nonsignificant correlation between TS and FM score (r = 0.22, P = 0.078), with higher FM scores associated with increased pain facilitation. No QST outcomes correlated with FM score in males (all P > 0.05; Table 2 ). CPM was not related to FM score in either sex.
Pain Sensitivity Across FM Score Tertiles in Females
To further explore the relationship between FM score and QST, females were separated into FM score tertiles (low, moderate, and high). This analysis was not conducted in males given their lack of association between FM score and QST (Table 2) . Because left-sided and right-sided PPTs were not statistically different in females, left and right PPTs for each location except the knees were collapsed together for clarity. ANCOVA revealed that female PPTs measured at the surgical knee (P = 0.037), lower leg (P = 0.007), trapezius (P = 0.025), and wrist (P = 0.005) significantly differed between FM tertiles, demonstrating a stepwise increase in pain sensitivity by tertile (Fig. 2) . Pairwise comparisons showed that this was primarily driven by the differences between low and high tertiles (all P ≤ 0.011). ANCOVA also revealed differences in thumbnail Pain50 (P = 0.052) and tolerance (P = 0.058), and nonsurgical knee PPT (P = 0.088) across FM tertiles that approached significance, with significant pairwise comparisons between low and high FM tertiles for Pain50 (P = 0.018), tolerance (P = 0.021), and nonsurgical knee PPT (P = 0.030).
Correlation Between Surgical Knee and Remote Body Site Pain Sensitivity in Females
We then examined the correlation between PPT at the surgical knee with PPTs at other body sites. As above, this analysis was not conducted in males given their lack of association between FM score and QST. Results showed that as FM scores increased, the associations between PPT at the surgical knee with PPTs at remote sites became stronger in a stepwise manner (Fig. 3) . Spearman correlations between surgical knee PPT and bilateral trapezius PPT increased from 0.58 (P = 0.012) to 0.71 (P = 0.001) to 0.78 (P < 0.001) from low to moderate to high tertiles, respectively. Likewise, correlations with bilateral wrist increased from 0.40 (P = 0.107) to 0.45 (P = 0.056) to 0.68 (P = 0.001). Lastly, correlations between surgical knee and bilateral lower leg increased from 0.52 (P = 0.029) to 0.54 (P = 0.016) to 0.73 (P < 0.001). The correlation between PPT at the surgical knee and contralateral knee which was also likely affected by OA was consistently strong across FM score tertiles.
Missing Data
The number of participants with missing self-report data were: 2 (1.6% of the analyzed, n = 129) for ethnicity and race; 5 (3.9%) for HADS depression and positive affect; 6 (4.7%) for HADS anxiety and all WOMAC scales; 7 (5.4%) for painDETECT; 8 (6.2%) for surgical knee BPI; 13 (10.0%) for CSQ catastrophizing. For the following QST outcomes, the number of participants with missing data were: 2 (1.6%) for MAST-derived thumbnail PPT, Pain50, tolerance; 7 (5.4%) for TS; 12 (9.3%) for CPM; and 31 (24.0%) for algometerderived PPT variables. The high number of missing PPT data was due to an algometer malfunction.
DISCUSSION
FM scores were previously shown to predict perioperative and postsurgical pain outcomes, 12,13 leading us to suggest that the FM survey criteria may help to identify patients with centralized pain. A critical component of the centralized pain construct is diffuse hyperalgesia measured by QST. In this study, we examined the relationship between FM scores and QST in patients with knee OA. Results showed that, in females only, higher FM scores were associated with increased pressure pain sensitivity at the surgical knee as well as at several remote body sites. This is consistent with other studies showing a relationship between pain sensitivity at distal or asymptomatic sites and OA symptoms. 33, 34 The present results represent the first demonstration to our knowledge of a relationship between QST and FM scores, providing convergent support that the FM survey criteria may represent a self-report measure of pain centralization. 
Pain Centralization in OA
Knee OA is traditionally conceptualized as a peripheral nociceptive pain condition resulting from damage and inflammation in the knee. However, a significant disparity exists between reported pain in OA and identifiable joint pathology on radiographic imaging 35, 36 : some patients reporting pain have minimal findings on imaging, whereas others have extensive joint pathology on imaging but report little pain, suggesting that at least a subset of knee OA patients have predominantly centralized pain. 37 This hypothesis is supported by extensive QST findings demonstrating abnormal pain processing in OA subgroups consistent with centralized pain, 26, 38, 39 including multisite hyperalgesia and impaired endogenous pain modulation. This is corroborated further by neuroimaging data showing altered pain-related processing and morphology in the OA brain. 40, 41 Here, <6% of female OA patients met criteria for FM. To ensure that our findings were not driven by these patients, we performed a secondary analysis using only patients who were subthreshold for being classified as "FM positive." In agreement with our primary findings, non-FM female patients with higher FM scores also demonstrated increased sensitivity throughout the body, suggesting that the FM score is useful for identifying OA patients with centralized pain regardless of their FM classification.
Sex Differences in Centralized Pain
The association between FM score and QST was only observed in females, suggesting that the FM survey criteria probe a dimension of centralized pain that is unique to females. While not anticipated, 33 this finding is supported by a literature demonstrating significant sex differences in clinical and experimental pain, 28, 30, 42, 43 and in fMRI studies of activation and connectivity patterns within and between brain regions involved in pain processing. 44, 45 Consistent with these studies, females here showed higher FM scores, pain intensity, catastrophizing, anxiety, depression, and pressure pain sensitivity compared with males. Importantly, the association between FM score and QST observed in females was not driven by their higher levels of clinical pain and psychological symptoms. Beyond the aforementioned sex differences in neural pain processing, it is also possible that hormonal (eg, estrogen level, meonopausal status) and genetic factors contributed to the female-specific associations observed in the present study. Future studies examining the influence of these factors are warranted. 30, 46 Moreover, studies examining sex and FM score with other QST modalities (eg, thermal) may produce different results, especially given recent findings demonstrating unique sensory profiles within knee OA patients. 47 Regardless, it remains unclear why the relationship between pain sensitivity and FM score was observed only in females. It should be noted, however, that the ability of the FM score to predict postsurgical outcomes was generalizable to both males and females. 11, 13 FM Score Associated With Pressure Sensitivity but Not CPM or TS Across the body, nearly all measures of pressure pain sensitivity in females were related to FM score (Table 2) , supporting the association between diffuse hyperalgesia and pain centralization. This suggests that the FM survey criteria are at least partially evaluating the static "tone" of central nervous system (CNS) pain systems. However, CPM and TS, both considered dynamic measures of pain modulation, failed to show a similar relationship. CPM is an experimental method used to evaluate the integrity of endogenous pain inhibitory systems, whereas TS assesses facilitative pain mechanisms. Both CPM and TS have been shown to be dysfunctional in various pain syndromes and predictive of postsurgical outcomes. 4, 5, 48, 49 Failure to observe associations between these measures and the FM score suggests either that these tests are not measuring what has been postulated, or that the FM survey criteria are not probing pain modulatory pathways. Several studies have also failed to demonstrate a relationship between CPM and clinical outcomes, including self-reported pain intensity 36, 50 and number of painful body sites 51 -a significant component of the FM score. It is also becoming evident that different CPM paradigms can yield conflicting results, even in the same individuals. 27, 52 Therefore, it is possible that other CPM and TS paradigms, including those assessed with neuroimaging 53 would show a relationship with the FM score.
Females were divided into FM score tertiles (low, moderate, and high) to better examine the relationship between QST and FM scores. We observed a stepwise increase in pain sensitivity as FM score tertile increased, with the greatest differences observed between high and low tertiles. This suggests that individuals with the highest FM scores may represent a unique pain phenotype compared with those with lower FM scores. This distinction may have important clinical significance for pain management: in patients with knee OA, higher FM scores would indicate the potential for improved outcomes with centrally acting therapies over peripheral interventions.
FM scores were also associated with the degree to which pain sensitivities correlated across the body. In individuals with purely localized nociceptive pain, such as that following acute injury, sensitivity at the injured site is normally expected to be increased (hyperalgesia), with uninjured body sites maintaining a baseline level of pain sensitivity. The correlation between sensitivity at the injured site and sensitivity at distant uninjured sites would therefore be low. In contrast, in individuals with centralized pain, augmented CNS pain processing is presumed to impart a global increase in pain sensitivity that would manifest as widespread hyperalgesia. In support of this, we showed that as FM scores increased, not only did pain sensitivity increase, but there was an increased association of pain sensitivities between remote body sites. Although speculative, this coupling may reflect an altered CNS process that effectively unifies pain signals from distant and distinct locations. This suggests that the FM score reflects not only a CNS process of pain augmentation, but also one of widespread pain integration and unification.
Limitations
This study has several limitations. Although our overall sample was larger than most studies examining these issues, it yielded relatively small subgroups when divided by sex and FM score tertile. Patients were older surgical OA candidates; it is unclear if these findings would be applicable to younger individuals or those with OA of lesser severity. All QST measures were pressure-based, and other stimulus modalities were not assessed. Furthermore, as this is a singlecenter university study with mostly Caucasian patients, the generalizability of our findings to other populations is unknown.
CONCLUSIONS
We demonstrated a relationship between QST and FM score in females with knee OA suggesting that the 2011 FM survey criteria may provide a useful measure of centralized pain. As a brief, self-report tool that does not require administration by a health care provider or the resource burden of other measures of central pain processing (eg, neuroimaging and QST), there is potential for its clinical implementation in pain management decision making.
